Ligand News and Research

RSS
Nanoviricides become registered trademark under USPTO

Nanoviricides become registered trademark under USPTO

AVEO Pharmaceuticals presents data on potential utility of Notch1-specific monoclonal antibody at 101st AACR

AVEO Pharmaceuticals presents data on potential utility of Notch1-specific monoclonal antibody at 101st AACR

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

New computer simulation technique could speed up drug discovery process

New computer simulation technique could speed up drug discovery process

Trevena commences Phase I trial of TRV120027 biased ligand for acute decompensated heart failure

Trevena commences Phase I trial of TRV120027 biased ligand for acute decompensated heart failure

Overcoming resistance - new options for the treatment of ovarian cancer

Overcoming resistance - new options for the treatment of ovarian cancer

Research opens way for development of new preventions and treatments for breast cancer

Research opens way for development of new preventions and treatments for breast cancer

Study suggests new ways to improve anti-cancer chemotherapies

Study suggests new ways to improve anti-cancer chemotherapies

Indispensable role of Mindin in innate and adaptive immunity

Indispensable role of Mindin in innate and adaptive immunity

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Scientists link gene expression profiling effort to identify potential novel therapeutic for ALS

Scientists link gene expression profiling effort to identify potential novel therapeutic for ALS

Two-drug combination destroys precancerous colon polyps

Two-drug combination destroys precancerous colon polyps

Tips offered in April 2010 issue of American Journal Of Pathology

Tips offered in April 2010 issue of American Journal Of Pathology

Blocking Bak inhibitors can be promising strategy in limiting resistance of cancer to TRAIL

Blocking Bak inhibitors can be promising strategy in limiting resistance of cancer to TRAIL

Dual role of Notch signalling pathway

Dual role of Notch signalling pathway

Study offers new possibilities for breast and other cancer therapies

Study offers new possibilities for breast and other cancer therapies

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

Researchers identify a new mechanism for tumor control

Researchers identify a new mechanism for tumor control

Three researchers to be honored with SBS Award for achievement in biomolecular sciences and lead discovery

Three researchers to be honored with SBS Award for achievement in biomolecular sciences and lead discovery

Presence of SIBLING proteins in premalignant oral lesions may predict oral cancer

Presence of SIBLING proteins in premalignant oral lesions may predict oral cancer